A previous study uncovered that over‐expression of TRAF6 could enhance the glioblastoma cell resistance against Temozolomide.[34] These results revealed the potential pharmacological consequences of perturbing miRNA regulations depending on A‐to‐I RNA editing. Here, TRAF6 is linked to glioblastoma.